Investment
Features
FeesSafety
Academy
More
Pluang+

IBM partners with OpenAI to embed GPT-5.6 in AI platform for secure, scalable enterprise AI solutions.

Market News
13 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

IBM announced a strategic partnership with OpenAI to integrate OpenAI's advanced models like GPT-5.6 into IBM Consulting's AI platform. This collaboration aims to help enterprises modernize legacy systems, automate workflows, and enhance cybersecurity with AI-driven solutions across industries such as finance, government, and retail. IBM will deploy specialized teams trained through the OpenAI Partner Network and launch a dedicated OpenAI Practice to accelerate AI adoption securely at scale. The partnership also focuses on managing AI risks and advancing application modernization to drive measurable business outcomes.

More News (IBM)

IBM partners with OpenAI to expand AI tools to enterprise clients via IBM Consulting.

IBM partners with OpenAI to expand AI tools to enterprise clients via IBM Consulting.

IBM has partnered with OpenAI to bring OpenAI's AI models and tools, including GPT-5.6 and Codex, to more enterprise customers through IBM's global consulting business. The deal involves joint marketing and development of industry-specific AI solutio...

Market News
Bullish
17 hours ago
IBM's quantum breakthrough shifts CFO focus from tech to economic value and cybersecurity readiness.

IBM's quantum breakthrough shifts CFO focus from tech to economic value and cybersecurity readiness.

IBM's recent quantum computing research shows quantum systems can outperform classical computers on specific problems, marking a technical milestone. However, CFOs should prioritize the economic impact, including costs of runtime, integration, and ta...

Market News
Neutral
18 hours ago
MMR vaccine split faces years-long FDA hurdles; IBM partners with OpenAI for AI boost; Jack in the Box shows early recovery signs.

MMR vaccine split faces years-long FDA hurdles; IBM partners with OpenAI for AI boost; Jack in the Box shows early recovery signs.

President Trump's executive order to separate the combined MMR vaccine into individual shots faces significant regulatory and manufacturing challenges, with FDA approval potentially taking up to 10 years. Merck and GSK, the only licensed producers of...

Market News
Neutral
21 hours ago
Kyndryl stock dips 3.77% in 10 days but shows 12.85% growth potential with strong financial health.

Kyndryl stock dips 3.77% in 10 days but shows 12.85% growth potential with strong financial health.

Kyndryl Holdings, an IT infrastructure services provider spun off from IBM, has seen its stock rise nearly 12% over the past 30 days but recently dipped 3.77% in the last 10 days, possibly creating a buying opportunity. Analysts forecast a 12.85% ups...

Analyst Insights
Bullish
1 day ago
IBM shares plunge 25% after CEO warns of weak Q2 revenue and mainframe issues.

IBM shares plunge 25% after CEO warns of weak Q2 revenue and mainframe issues.

IBM's CEO revealed disappointing Q2 2026 results, with revenue growth only 1% and a 7% drop in Infrastructure revenue, mainly due to problems with IBM Z mainframe performance. This announcement caused IBM shares to fall 25%, wiping out over $68 billi...

Market News
Bearish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App